Janus Henderson Group’s Rhythm Pharmaceuticals RYTM Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $89.3M | Sell |
1,411,902
-243,448
| -15% | -$15.4M | 0.04% | 285 |
|
2025
Q1 | $90.7M | Buy |
1,655,350
+435,796
| +36% | +$23.9M | 0.05% | 278 |
|
2024
Q4 | $68.3M | Buy |
1,219,554
+621,432
| +104% | +$34.8M | 0.03% | 326 |
|
2024
Q3 | $31.3M | Buy |
598,122
+4,480
| +0.8% | +$235K | 0.02% | 487 |
|
2024
Q2 | $24.4M | Sell |
593,642
-27,785
| -4% | -$1.14M | 0.01% | 532 |
|
2024
Q1 | $26.9M | Sell |
621,427
-465
| -0.1% | -$20.1K | 0.01% | 513 |
|
2023
Q4 | $28.6M | Sell |
621,892
-443,853
| -42% | -$20.4M | 0.02% | 477 |
|
2023
Q3 | $24.4M | Sell |
1,065,745
-12,462
| -1% | -$286K | 0.02% | 496 |
|
2023
Q2 | $17.8M | Sell |
1,078,207
-19,366
| -2% | -$319K | 0.01% | 576 |
|
2023
Q1 | $19.6M | Sell |
1,097,573
-142,580
| -11% | -$2.54M | 0.01% | 585 |
|
2022
Q4 | $36.1M | Sell |
1,240,153
-1,882,013
| -60% | -$54.8M | 0.03% | 444 |
|
2022
Q3 | $76.5M | Buy |
3,122,166
+1,042,089
| +50% | +$25.5M | 0.03% | 418 |
|
2022
Q2 | $8.63M | Sell |
2,080,077
-870,925
| -30% | -$3.61M | 0.01% | 722 |
|
2022
Q1 | $34M | Sell |
2,951,002
-182,933
| -6% | -$2.11M | 0.02% | 611 |
|
2021
Q4 | $31.3M | Sell |
3,133,935
-48,447
| -2% | -$484K | 0.01% | 679 |
|
2021
Q3 | $41.6M | Sell |
3,182,382
-743,668
| -19% | -$9.71M | 0.02% | 603 |
|
2021
Q2 | $76.9M | Sell |
3,926,050
-161,973
| -4% | -$3.17M | 0.03% | 447 |
|
2021
Q1 | $87M | Sell |
4,088,023
-403,742
| -9% | -$8.59M | 0.04% | 406 |
|
2020
Q4 | $134M | Buy |
4,491,765
+105,395
| +2% | +$3.13M | 0.06% | 302 |
|
2020
Q3 | $95.1M | Sell |
4,386,370
-24,118
| -0.5% | -$523K | 0.05% | 343 |
|
2020
Q2 | $98.4M | Buy |
4,410,488
+91,455
| +2% | +$2.04M | 0.06% | 318 |
|
2020
Q1 | $65.7M | Buy |
4,319,033
+13,785
| +0.3% | +$210K | 0.05% | 381 |
|
2019
Q4 | $98.8M | Buy |
4,305,248
+898,500
| +26% | +$20.6M | 0.05% | 381 |
|
2019
Q3 | $73.6M | Buy |
3,406,748
+114,423
| +3% | +$2.47M | 0.04% | 460 |
|
2019
Q2 | $72.4M | Buy |
3,292,325
+10,556
| +0.3% | +$232K | 0.04% | 477 |
|
2019
Q1 | $90M | Buy |
3,281,769
+18,594
| +0.6% | +$510K | 0.05% | 409 |
|
2018
Q4 | $87.7M | Buy |
3,263,175
+212,337
| +7% | +$5.71M | 0.06% | 380 |
|
2018
Q3 | $89M | Buy |
3,050,838
+759,053
| +33% | +$22.1M | 0.05% | 428 |
|
2018
Q2 | $71.6M | Buy |
2,291,785
+1,197,165
| +109% | +$37.4M | 0.04% | 458 |
|
2018
Q1 | $21.8M | Buy |
1,094,620
+339,460
| +45% | +$6.76M | 0.01% | 779 |
|
2017
Q4 | $21.9M | Buy |
+755,160
| New | +$21.9M | 0.01% | 743 |
|